Back to Search
Start Over
Discrepancies in the management of acquired cold contact urticaria: Results of a French-speaking urticaria experts questionnaire survey.
- Source :
-
The World Allergy Organization journal [World Allergy Organ J] 2022 Aug 21; Vol. 15 (9), pp. 100688. Date of Electronic Publication: 2022 Aug 21 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Acquired cold contact urticaria (ACU) is a putatively serious condition, because of the risk of anaphylactic shock whenever patients are massively exposed to cold atmosphere/water, raising the question of the prescription of an "emergency kit" with oral antihistamines and epinephrine auto-injector. We performed an online survey to evaluate how French-speaking urticaria experts manage ACU. According to the 2016 consensus recommendations on chronic inducible urticarias, all the participants perform at least 1 of the available provocation tests and 84.2%, 77.8%, and 88.9% prescribe on-label use of second generation anti-H1 antihistamines (2GAH1) as a first line treatment, updosed 2GAH1 as a second line treatment, and omalizumab as a third line treatment, respectively. Interestingly, 44.4% of the practitioners always prescribe a continuous background treatment, versus 11.1% prescribing only on-demand therapy. Also, 11.7% of participants always prescribe an epinephrine auto-injector, 70.6% sometimes do, and 17.6% never do. Finally, 89.5% authorize swimming under strict conditions but 36.8% and 68.4% contra-indicate other water sports and occupational cold exposure, respectively.<br /> (© 2022 The Authors.)
Details
- Language :
- English
- ISSN :
- 1939-4551
- Volume :
- 15
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- The World Allergy Organization journal
- Publication Type :
- Academic Journal
- Accession number :
- 36092949
- Full Text :
- https://doi.org/10.1016/j.waojou.2022.100688